首頁 > 市場調查報告書 > 製藥

糖尿病

市場調查報告書

商品編碼

1085375

糖尿病設備、治療藥的與全球市場:各類別(診斷監測，治療)，各疾病類型，各地區-規模，佔有率，展望，機會分析(2022年～2028年)

Diabetes Devices and Drugs Market, By Category (Diagnosis and Monitoring, Therapeutics ), By Disease Type, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

出版日期: 2022年05月29日 | 出版商:

Coherent Market Insights | 英文 183 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

新興國家的糖尿病診斷、治療相關認知度低，預計阻礙糖尿病設備、治療藥市場成長。

本報告提供全球糖尿病設備、治療藥市場的相關調查，市場展望，市場動態，市場分析，競爭情形等全面性資訊。

簡介
- 市場佔有率分析(%)(2022年～2028年)
- 與前一年同期比較成長分析(2017年～2028年)
- 市場區隔趨勢
診斷和監測
- 簡介
- 市場規模與預測，及與前一年同期比較成長率(100萬美元)(2017年～2028年)
- 市場區隔趨勢
血糖監測系統設備
其他的實驗設備
糖尿病監測的軟體程序
人工胰臟
治療
- 簡介
- 市場規模與預測，及與前一年同期比較成長率(100萬美元)(2017年～2028年)
- 市場區隔趨勢
胰島素
胰島素通知
口服血糖降落藥
細胞治療

第5章全球糖尿病設備、治療藥市場:各疾病類型(100萬美元)(2017年～2028年)

簡介
- 市場佔有率分析(%)(2022年～2028年)
- 與前一年同期比較成長分析(2017年～2028年)
- 市場區隔趨勢
第二型糖尿病
- 簡介
- 市場規模與預測，及與前一年同期比較成長率(100萬美元)(2017年～2028年)
- 市場區隔趨勢
第一型糖尿病
- 簡介
- 市場規模與預測，及與前一年同期比較成長率(100萬美元)(2017年～2028年)
- 市場區隔趨勢

第6章全球糖尿病設備、治療藥市場:各地區(100萬美元)(2017年～2028年)

簡介
- 市場佔有率分析(%)(2022年～2028年)
- 與前一年同期比較成長分析(2017年～2028年)
- 市場區隔趨勢
北美
美國
加拿大
歐洲
英國
德國
義大利
法國
西班牙
俄羅斯
其他的歐洲
亞太地區
中國
印度
日本
東南亞國協
澳洲
韓國
其他的亞太地區
南美
巴西
墨西哥
阿根廷
其他的南美
中東
GCC各國
以色列
其他的中東
非洲
北非
中非
南非

第7章競爭情形

企業簡介

Abbott Laboratories
Bristol-Myers Squibb
DexCom, Inc.
Eli Lilly and Company
Companion Medical
GlaxoSmithKline plc
Glenmark Pharmaceuticals
Johnson &Johnson
Lupin Ltd.
F. Hoffmann-La Roche AG
Sanofi

第8章 Section

參考文件
調查手法
關於本公司與營業窗口

簡介目錄

Product Code: CMI3857

Diabetes devices and drugs (diagnosis, monitoring and therapeutics) consists of diabetes management right from diagnosis, monitoring, till treatment. Diabetes is characterized by high presence of blood glucose, also called blood sugar, in the body. There are three main types of diabetes: type 1, type 2, and gestational diabetes. Oral glucose tolerance testing and hemoglobin A1c (HbA1c) testing are some of the tests used in the diagnosis of the chronic condition. Treatment options include use of insulin, oral hypoglycemic agents, and others.

Restraints of the Global Diabetes Devices and Drugs (Diagnosis, Monitoring and Therapeutics) Market

Lack of awareness about diabetes diagnostics and treatment, especially in emerging economies, is expected to hinder growth of the global diabetes devices and drugs (diagnosis, monitoring, and therapeutics) market. Moreover, recall of diabetes drugs is also expected to limit growth of the market.

Key features of the study:

This report provides in-depth analysis of the global diabetes devices and drugs (diagnosis, monitoring and therapeutics) market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global diabetes devices and drugs (diagnosis, monitoring and therapeutics) market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Abbott Laboratories, Bristol-Myers Squibb, DexCom, Inc., Eli Lilly and Company, Companion Medical, GlaxoSmithKline plc, Glenmark Pharmaceuticals, Johnson & Johnson, Lupin Ltd., F. Hoffmann-La Roche AG, and Sanofi.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global diabetes devices and drugs (diagnosis, monitoring and therapeutics) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

Global Diabetes Devices and Drugs (Diagnosis, Monitoring and Therapeutics) Market, By Category:
- Diagnosis and Monitoring
Blood Glucose Monitoring Devices
Other Testing Devices
Software Programs for Diabetes Monitoring
Artificial Pancreas
- Therapeutics
Insulin
Insulin Delivery
Oral Hypoglycemic Agents
Cell Therapies
Global Diabetes Devices and Drugs (Diagnosis, Monitoring and Therapeutics) Market, By Disease Type:
- Type 2 Diabetes
- Type 1 Diabetes
Global Diabetes Devices and Drugs (Diagnosis, Monitoring and Therapeutics) Market, By Geography:
- North America
By Category
- Diagnosis and Monitoring
  - Blood Glucose Monitoring Devices
  - Other Testing Devices
  - Software Programs for Diabetes Monitoring
  - Artificial Pancreas
- Therapeutics
  - Insulin
  - Insulin Delivery
  - Oral Hypoglycemic Agents
  - Cell Therapies
By Disease Type
- Type 2 Diabetes
- Type 1 Diabetes
By Country:
- U.S.
- Canada
- Europe
By Category
- Diagnosis and Monitoring
  - Blood Glucose Monitoring Devices
  - Other Testing Devices
  - Software Programs for Diabetes Monitoring
  - Artificial Pancreas
- Therapeutics
  - Insulin
  - Insulin Delivery
  - Oral Hypoglycemic Agents
  - Cell Therapies
By Disease Type
- Type 2 Diabetes
- Type 1 Diabetes
By Country:
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
By Category
- Diagnosis and Monitoring
  - Blood Glucose Monitoring Devices
  - Other Testing Devices
  - Software Programs for Diabetes Monitoring
  - Artificial Pancreas
- Therapeutics
  - Insulin
  - Insulin Delivery
  - Oral Hypoglycemic Agents
  - Cell Therapies
By Disease Type
- Type 2 Diabetes
- Type 1 Diabetes
By Country:
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
By Category
- Diagnosis and Monitoring
  - Blood Glucose Monitoring Devices
  - Other Testing Devices
  - Software Programs for Diabetes Monitoring
  - Artificial Pancreas
- Therapeutics
  - Insulin
  - Insulin Delivery
  - Oral Hypoglycemic Agents
  - Cell Therapies
By Disease Type
- Type 2 Diabetes
- Type 1 Diabetes
By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East:
By Category
- Diagnosis and Monitoring
  - Blood Glucose Monitoring Devices
  - Other Testing Devices
  - Software Programs for Diabetes Monitoring
  - Artificial Pancreas
- Therapeutics
  - Insulin
  - Insulin Delivery
  - Oral Hypoglycemic Agents
  - Cell Therapies
By Disease Type
- Type 2 Diabetes
- Type 1 Diabetes
By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
By Category
- Diagnosis and Monitoring
  - Blood Glucose Monitoring Devices
  - Other Testing Devices
  - Software Programs for Diabetes Monitoring
  - Artificial Pancreas
- Therapeutics
  - Insulin
  - Insulin Delivery
  - Oral Hypoglycemic Agents
  - Cell Therapies
By Disease Type
- Type 2 Diabetes
- Type 1 Diabetes
By Country/Region:
- Central Africa
- South Africa
- North Africa
Company Profiles
- Abbott Laboratories *
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
- Bristol-Myers Squibb
- DexCom, Inc.
- Eli Lilly and Company
- Companion Medical
- GlaxoSmithKline plc
- Glenmark Pharmaceuticals
- Johnson & Johnson
- Lupin Ltd.
- F. Hoffmann-La Roche AG
- Sanofi

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description

Market Definition and Scope
- Executive Summary
Market Snippet, By Category
Market Snippet, By Disease Type
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics

Drivers
Restraints
Market Opportunities
- Impact Analysis
- Key Developments
- Regulatory Scenario
- PEST Analysis

4. Global Diabetes Devices and Drugs (Diagnosis, Monitoring and Therapeutics) Market, By Category, 2017 - 2028 (US$ Mn)

Introduction

Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
- Diagnosis and Monitoring
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
- Blood Glucose Monitoring Devices
- Other Testing Devices
- Software Programs for Diabetes Monitoring
- Artificial Pancreas
- Therapeutics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
- Insulin
- Insulin Delivery
- Oral Hypoglycemic Agents
- Cell Therapies

5. Global Diabetes Devices and Drugs (Diagnosis, Monitoring and Therapeutics) Market, By Disease Type, 2017 - 2028 (US$ Mn)

Introduction

Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
- Type 2 Diabetes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
- Type 1 Diabetes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends

6. Global Diabetes Devices and Drugs (Diagnosis, Monitoring and Therapeutics) Market, By Regions, 2017 - 2028 (US$ Mn)

Introduction

Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
- North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- U.S.
- Canada
- Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- North Africa
- Central Africa
- South Africa

7. Competitive Landscape

Company Profiles

Abbott Laboratories
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bristol-Myers Squibb
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
DexCom, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Eli Lilly and Company
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Companion Medical
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GlaxoSmithKline plc
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Glenmark Pharmaceuticals
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Johnson & Johnson
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Lupin Ltd.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
F. Hoffmann-La Roche AG
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies